What serum tests are recommended for evaluating inflammatory bowel disease, and is there a blood test that can diagnose microscopic colitis or autoimmune colitis?

Serum Tests for Inflammatory Bowel Disease

For suspected IBD, obtain a complete blood count, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), comprehensive metabolic panel including liver enzymes and albumin, and fecal calprotectin—these are the essential laboratory tests, though none are diagnostic on their own. 1, 2

Core Laboratory Panel for IBD Evaluation

The most recent ECCO-ESGAR-ESP-IBUS guidelines (2025) emphasize that no single blood test diagnoses IBD—diagnosis requires a combination of clinical symptoms, laboratory tests, endoscopy, histology, and imaging 2. However, specific serum tests serve important roles:

Essential Blood Tests:

• Complete blood count: Detects anemia (hemoglobin <13 g/dL for men, <12 g/dL for women), leukocytosis, and thrombocytosis 1, 3
• C-reactive protein (CRP): More sensitive than ESR for acute inflammation; correlates better with endoscopic activity in Crohn's disease than ulcerative colitis 1
• Erythrocyte sedimentation rate (ESR): Less sensitive than CRP but still useful 1
• Comprehensive metabolic panel: Electrolytes, renal function, liver enzymes 1
• Serum albumin/pre-albumin: Assesses nutritional status and inflammation severity 1
• Iron studies: Ferritin <30 μg/L indicates iron deficiency without inflammation; ferritin 30-100 μg/L with inflammation suggests combined deficiency 3

Fecal Biomarkers (Superior to Serum Tests):

Fecal calprotectin is the single most sensitive non-invasive biomarker for distinguishing IBD from IBS, with 88% sensitivity and 92% specificity at cutoffs ≤50 μg/g 2. This outperforms all serum inflammatory markers 4.

Serologic Antibody Tests (Limited Clinical Utility):

The evidence shows these have poor diagnostic accuracy and should NOT be routinely ordered 3:

• pANCA (perinuclear anti-neutrophil cytoplasmic antibodies): Found in 65% of UC patients but only 34.9% sensitivity with 95.9% specificity 2, 5
• ASCA (anti-Saccharomyces cerevisiae antibodies): Present in 44% of Crohn's disease patients, highly specific but low sensitivity 6, 7
• Anti-OmpC, anti-GP2, CBir1: Minimal additional diagnostic value 3, 2

These antibody panels cannot reliably differentiate UC from Crohn's disease or diagnose IBD 3. The 2019 ECCO-ESGAR guideline explicitly states serological markers have "rather limited accuracy" and are "ineffective at differentiating colonic CD from UC" 3.

---

Blood Tests for Microscopic Colitis and Autoimmune Colitis

There is NO blood test that can diagnose microscopic colitis—colonoscopy with colonic biopsies is the only diagnostic method. 4

Microscopic Colitis:

The 2019 AGA Technical Review definitively states: "We did not find studies of blood or inflammatory markers in microscopic colitis" 4. The 2026 Annual Review of Medicine confirms "there are no established biomarkers to facilitate noninvasive diagnosis" of microscopic colitis 8.

Key diagnostic facts:

• Colonoscopy appears macroscopically normal in microscopic colitis 9, 8
• Diagnosis requires histological examination of colonic biopsies 4
• Biopsies from ascending and transverse colon are essential—rectosigmoid biopsies alone miss 34-43% of cases 9
• Affects approximately 10% of patients with chronic watery diarrhea, most commonly those over age 60 4

Important Clinical Pitfall:

One-third of microscopic colitis patients present with chronic constipation rather than diarrhea 10. The absence of watery diarrhea should not exclude this diagnosis.

Autoimmune Colitis Context:

While 39% of microscopic colitis patients have concurrent autoimmune diseases 10, and the condition itself has autoimmune features 11, no specific blood test diagnoses the colitis itself. You may detect associated autoimmune conditions (thyroid antibodies, celiac serology with IgA-tTG 4), but the colonic inflammation requires tissue diagnosis.

---

Practical Algorithm for Suspected IBD:

1. Order initial blood work: CBC, CRP, comprehensive metabolic panel, albumin, iron studies
2. Order fecal calprotectin (>50 μg/g suggests IBD with 87% sensitivity, 92% specificity) 2
3. Exclude infections: Stool cultures, Clostridium difficile toxin, ova and parasites if indicated 1, 3
4. Proceed to ileocolonoscopy with biopsies regardless of blood test results—this is mandatory for diagnosis 3, 2
5. Add cross-sectional imaging (intestinal ultrasound or MRE) for complete evaluation 2

Do not rely on serology panels (pANCA/ASCA) for diagnosis—they add minimal value and should not delay endoscopic evaluation 3.